SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : VVUS: VIVUS INC. (NASDAQ) -- Ignore unavailable to you. Want to Upgrade?


To: RT who wrote (3560)12/13/1997 9:19:00 AM
From: blankmind  Respond to of 23519
 
<<Question 1 = NO
Question 2 = UNDER FDA FAST TRACK REVIEW >>

RT,

If Pfizer's drug hasn't even been approved yet, I think VVUS has more lead time than some think.

-- Also, if VVUS's product works the best, and is painless to administer, then the traffic in to the doctors' offices will actually increase sales for VVUS. -- I'm not saying anything new. All this was stated over & over on the confer call.

-- Out.